Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3316 Clemizole hydrochlorideTarget: Histamine H1 Receptors|TRPC channelSummary: H1 histamine receptor antagonist
-
A3259 BMS-927711Summary: CGRP receptor antagonist
-
A3282 CariprazineSummary: D2/D3 partial agonist,antipsychotic drug
-
A3298 CetirizineSummary: Antihistamine
-
A3299 CevimelineSummary: Muscarinic receptor agonist
-
A3300 Cevimeline hydrochloride hemihydrateSummary: Agonist of muscarinic receptor (M1/M3)
-
A3315 ClemizoleSummary: H1 histamine receptor antagonist
-
A3317 Clozapine N-oxide (CNO)1 CitationTarget: DREADD LigandsSummary: Metabolite of clozapine, used in chemogenetics.
-
A3330 CP-809101Summary: 5-HT2C receptor agonist
-
A3331 CP-809101 hydrochlorideSummary: 5-HT2C receptor agonist, potent and selective